• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Intuitive Surgical Inc.

    2/11/25 4:01:25 PM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001632901
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    INTUITIVE SURGICAL, INC.
    SEC File Number
    000-30713
    Address of Issuer
    1020 KIFER ROAD
    SUNNYVALE
    CALIFORNIA
    94086
    Phone
    (408) 523-2100
    Name of Person for Whose Account the Securities are To Be Sold
    MYRIAM CURET MCADAMS
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    408240618.0035665696402/11/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common02/10/2025Restricted StockISSUERCheckbox not checked40802/10/2025Not Applicable

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    MYRIAM CURET MCADAMS
    1020 KIFER ROAD
    SUNNYVALE � CA � 94086
    Common11/12/2024134667217195.62

    144: Remarks and Signature

    Remarks
    Date of Notice
    02/11/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    08/13/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Myriam Curet McAdams

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ISRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    6/5/2025Hold → Buy
    Erste Group
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    5/30/2024$500.00Buy
    Goldman
    11/17/2023$318.00Buy
    HSBC Securities
    7/19/2023$377.00Outperform
    Robert W. Baird
    More analyst ratings

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • 30 years of Innovation and Impact: Dan Larson's Inspiring Story

      SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

      5/27/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces FDA Clearance of da Vinci Single Port for Transanal Local Excision/Resection

      SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP's capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures - low anterior resection, total mesorec

      5/1/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Rosa David J. converted options into 1,358 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 0.30% to 231,756 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/10/25 12:36:53 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SVP & Chief Mfg and Supply Cha Brosius Mark sold $242,182 worth of shares (431 units at $561.91), decreasing direct ownership by 32% to 907 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/6/25 4:20:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • President Rosa David J. gifted 851 shares, decreasing direct ownership by 0.37% to 231,072 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/4/25 6:53:25 PM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Intuitive Surgical downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Intuitive Surgical from Hold to Sell and set a new price target of $440.00

      6/9/25 7:47:07 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Erste Group

      Erste Group upgraded Intuitive Surgical from Hold to Buy

      6/5/25 7:52:11 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Intuitive Surgical from Equal-Weight to Overweight and set a new price target of $650.00 from $522.00 previously

      12/2/24 6:57:53 AM ET
      $ISRG
      Industrial Specialties
      Health Care